文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

主动脉瓣狭窄中超声心动图第一时相射血分数的决定因素与预后价值

Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis.
PubMed 文献 · Heart · 2020-04-28

在149例主动脉瓣狭窄患者中回顾性测量第一时相射血分数(EF1),发现45%患者基线EF1低(<25%) despite 射血分数正常。EF1与主动脉瓣狭窄严重程度和心肌纤维化相关,是主动脉瓣置换或死亡的独立预测因子。

要点

  • EF1可量化主动脉瓣狭窄中早期、可逆的左室收缩功能障碍。
  • 低EF1与更严重的狭窄和更多心肌纤维化相关,且是AVR/死亡的独立预测因子。
  • AVR后EF1改善,提示其潜在可逆性。

核心结论

  • EF1量化主动脉瓣狭窄中早期、潜在可逆的收缩功能障碍,与全局后负荷和心肌纤维化相关,是主动脉瓣置换的独立预测因子。

研究设计与样本

  • 回顾性测量2012-2014年招募的主动脉瓣狭窄(峰值主动脉流速≥2 m/s)患者的超声心动图/心血管磁共振队列数据。
  • 共149例参与者,69.8%男性,年龄70(65-76)岁,平均压差33(21-42)mm Hg。

主要发现

  • 67例(45%)基线EF1低(<25%),尽管射血分数正常(67%(62%-71%))。
  • 低EF1患者主动脉瓣狭窄更严重(平均压差39(34-45)mm Hg vs 24(16-35)mm Hg,p<0.001)。
  • 低EF1患者心肌纤维化更多:iECV 24.2(19.6-28.7)mL/m2 vs 20.6(16.8-24.3)mL/m2,p=0.002;LGE患病率52% vs 20%,p<0.001。
  • Zva、iECV和梗死LGE是EF1的独立预测因子。
  • AVR后EF1改善(n=57,基线16(12-24)% vs 随访27%(22%-31%),p<0.001)。

临床怎么用

  • 在主动脉瓣狭窄患者中评估EF1有助于识别早期收缩功能障碍,尽管射血分数正常。
  • 低EF1患者可能需要更密切监测和考虑更早干预。

局限性

  • 回顾性研究设计。
  • 样本量有限(149例)。
  • EF1测量仅在部分患者中可获得(AVR后EF1 n=57)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: First-phase ejection fraction (EF1) is a novel measure of early left ventricular systolic dysfunction. We investigated determinants of EF1 and its prognostic value in aortic stenosis. METHODS: EF1 was measured retrospectively in participants of an echocardiography/cardiovascular magnetic resonance cohort study which recruited patients with aortic stenosis (peak aortic velocity of ≥2 m/s) between 2012 and 2014. Linear regression models were constructed to examine variables associated with EF1. Cox proportional hazards were used to determine the prognostic power of EF1 for aortic valve replacement (AVR, performed as part of clinical care in accordance with international guidelines) or death. RESULTS: Total follow-up of the 149 participants (69.8% male, 70 (65-76) years, mean gradient 33 (21-42) mm Hg) was 238 029 person-days. Sixty-seven participants (45%) had a low baseline EF1 (<25%) despite normal ejection fraction (67% (62%-71%)). Patients with low EF1 had more severe aortic stenosis (mean gradient 39 (34-45) mm Hg vs 24 (16-35) mm Hg, p<0.001) and more myocardial fibrosis (indexed extracellular volume (iECV) (24.2 (19.6-28.7) mL/m2 vs 20.6 (16.8-24.3) mL/m2, p=0.002; late gadolinium enhancement (LGE) prevalence 52% vs 20%, p<0.001). Zva, iECV and infarct LGE were independent predictors of EF1. EF1 improved post-AVR (n=57 with post-AVR EF1 available, baseline 16 (12-24) vs follow-up 27% (22%-31%); p<0.001). Low baseline EF1 was an independent predictor of AVR/death (HR 5.6, 95% CI 3.4 to 9.4), driven by AVR. CONCLUSION: EF1 quantifies early, potentially reversible systolic dysfunction in aortic stenosis, is associated with global afterload and myocardial fibrosis, and is an independent predictor of AVR.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Bing R, Gu H, Chin C, et al. Determinants and prognostic value of echocardiographic first-phase ejection fraction in aortic stenosis. Heart. 2020. PMID: 32345658. doi:10.1136/heartjnl-2020-316684

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。